Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells
Frontiers in Pharmacology · 27.07.2026 · 17
DOI: 10.3389/fphar.2026.1844144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.07.2026. Verfasst von Francesco Demetrio Lofaro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Melanoma remains one of the most lethal cancers due to its high metastatic capacity and resistance to current therapies, emphasizing the need for novel antineoplastic agents, including bioactive molecules from marine organisms, as potential sources of anticancer compound.
Aims
This study aimed to investigate, for the first time, the anticancer potential of Hallachrome (HC), an anthraquinone derived from the marine polychaete Halla parthenopeia , in A375 melanoma cells.
Methods
A375 melanoma cells were treated with HC in vitro to evaluate its impact on cell proliferation, migration, and morphology. Proteomic analysis was carried out to identify differentially expressed proteins in order to elucidate the biological processes modulated by the treatment. Mitochondrial morphology and function were analyzed by confocal microscopy and oxygen consumption rate, respectively, while mitochondrial membrane potential, intracellular reactive oxygen species (ROS) levels and GSH/GSSG ratio were evaluated by fluorescence-based assays.
Results
HC treatment significantly reduced melanoma cell proliferation and migration in vitro , accompanied by morphological alteration and apoptosis death. Proteomic profiling revealed differential expression of several proteins involved, for example, in membrane and mitochondria organization. Moreover, HC treatment induced severe mitochondrial dysfunction, characterized by ATP depletion, mitochondrial membrane depolarization, fragmentation of the mitochondrial network, altered intracellular ROS level and GSH/GSSG ratio.
Discussion
These findings suggest that HC inhibits melanoma cell survival by disrupting mitochondrial homeostasis and inducing energetic stress. Given the pivotal role of mitochondria in cancer progression, the ability of HC to interfere with mitochondrial functions supports its potential as a promising anticancer agent.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Zitieren
APA
Lofaro, F. D., Ferri, A., Mazzilli, A., Bonacorsi, S., Simonini, R., & Boraldi, F. (2026). Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1844144
Vancouver
Lofaro FD, Ferri A, Mazzilli A, Bonacorsi S, Simonini R, Boraldi F. Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1844144
BibTeX
@article{Lofaro2026,
author = {Lofaro, Francesco Demetrio and Ferri, Anita and Mazzilli, Alessia and Bonacorsi, Susanna and Simonini, Roberto and Boraldi, Federica},
title = {Hallachrome, a marine anthraquinone, impairs cell proliferation by acting as a functional mitochondrial uncoupler in A375 melanoma cells},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1844144}
}
EUVIMED